Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Edit Content

Nuclear Medicine at SKMCH&RC, Lahore

The Department of Nuclear Medicine at Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore is one of the most technologically advanced department in the country and the region; delivering comprehensive diagnostic and therapeutic applications of this unique specialty, which employs minute amount of radioactive material called “radiopharmaceutical” to study the function of body systems and organs. These state-of-the-art services are provided by qualified nuclear medicine physicians backed by a team of medical physicists, radiochemists, radiopharmacists, cyclotron engineers, technologists and nurses.


Departmental operations are governed by stringent international (International Atomic Energy Agency) and national (Pakistan Nuclear Regulatory Authority) regulations and our team of highly qualified nuclear medicine physicians ensure compliance with the quality and safety standards set for the safe and appropriate use of radiopharmaceuticals in medicine.

Our Expertise

The Department of Nuclear Medicine at SKMCH&RC offers a large diversity of diagnostic and therapeutic services, which play a central role in patient management.

 

To provide the diagnostic services, the Department of Nuclear Medicine is equipped with:

  • Two Time-of-Flight PET-CT scanners
  • Two Hybrid SPECT-CT gamma cameras
  • One Dual head Gamma camera
  • One DXA scanner

Portable Molybdenum-Technetium generators are the primary source of radio-active material. These are sourced from three internationally acclaimed and licensed vendors, to ensure quality as well as constant availability of Tc99m resources.

Radiopharmacy at SKMCH&RC, Lahore qualifies as Level-3C defined by IAEA criterion. It is equipped with state-of-the-art cGMP compliant synthesis and dispensing equipment. It houses intricate lead shielded Lemmarpax Isolators, conventional radiopharmacy and related USP compliant Quality Control equipment. Radiopharmacy synthesises complex radiopharmaceuticals 18F-FDG with on-site cyclotron and Ga68 radiopeptides with latest equipment in a sterile and aseptic environment.

We not only fulfil our requirement at our facilities in Lahore and Peshawar, but we also provide PET radiopharmaceuticals to other institutes in Lahore, as and when needed.

Images are processed and analysed on dedicated work stations and archived on the Picture Archiving Communications System (PACS), making SKMCH&RC a filmless digital setup. These images are accessible from dedicated systems in the hospital, which are password protected.

Radioactive iodine-131 is the treatment option for overactive thyroid (hyperthyroidism) and certain types of thyroid cancer. We, at SKMCH&RC, Lahore, have consultant led clinics and facility for in-patient admission of these patients after high dose therapy.

Nuclear medicine offers palliative treatment for metastatic bone pain with Sr-89 and Sm-153. Bone seeking radiopharmaceuticals are an effective modality in patients with metastatic cancer.

Diagnostic Nuclear Medicine: 
PET-CT: 

Oncology (cancer staging and follow-up), Neurology, Fever of unknown origin

Nuclear Oncology: 

PET-CT, Radioactive iodine (thyroid cancer), Gallium-67 (lymphoma, infection), MIBG (neuroendocrine tumour), Octreotide (somatostatin receptor studies), Sentinel lymph node

Nuclear Cardiology: 

Myocardial perfusion studies, MUGA, FDG PET

Genitourinary System: 

Dynamic renal imaging (DTPA, MAG3), DMSA, Captopril studies, Nuclear cystography, Testicular imaging

Musculoskeletal imaging [SPECT-CT]:

Bone scan, Bone Marrow colloid scans

Gastrointestinal Imaging:

Gastric emptying, GI Bleed, Meckel’s Scan

Hepatobiliary Imaging:

HIDA, Liver-Spleen colloid imaging

Pulmonary Imaging:

V/Q scans for pulmonary embolism / function assessment

Endocrine Imaging [SPECT-CT]:

Thyroid, parathyroid and adrenal imaging

Infection Imaging: [SPECT-CT]:

Gallium, FDG, Bone scan

Neurological Imaging:

Brain FDG PET-CT

Sentinel Lymph Node Scinitigraphy on SPECT/CT

Lymphoscintigraphy Studies on SPECT/CT

Bone Densitometry:

DXA scan

Therapeutic Nuclear Medicine:

Lu177- PSMA therapy for prostate cancer.

Lu177- DOTA therapy for neuroendocrine tumours.

Radioactive iodine (I131) therapy for benign and malignant thyroid disease & ablation.

Palliative treatment for metastatic bone pain with Sr-89 or Sm153

Thyroid cancer clinics / Thyroid multidisciplinary tumour board /clinics

Training Opportunities For Physicians

Department of Nuclear Medicine is committed to provide education and research activities for the employees. Nuclear medicine is affiliated with the College of Physicians and Surgeons of Pakistan (CPSP) for a 4-year training in FCPS Nuclear Medicine. Currently, the department has  for FCPS-II trainees. Additionally, we offer positions for 1-year fellowship in PET-CT and Nuclear medicine for post-FCPS candidates. Department also hosts visiting MSc. in Nuclear Medicine fellows from Pakistan Institute of Engineering and Applied Sciences (PIEAS) in Islamabad.

Student Electives

Elective opportunities are available for medical students in the department of Nuclear Medicine.